Kiniksa Pharmaceuticals International plc Class A share price logo

Kiniksa Pharmaceuticals International plc Class A

NASDAQ: KNSA

Mid Cap

$55.11

+0.90

(+1.66%)

as on

Kiniksa Pharmaceuticals International plc Class A Stock Performance

as on June 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $54.33
    $55.63
    downward going graph

    1.42%

    Downside

    0.94%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $26.27
    $59.87
    downward going graph

    52.33%

    Downside

    8.64%

    Upside

    downward going graph

Kiniksa Pharmaceuticals International plc Class A share price movements today

Previous Close
$54.21
Open
$55.63
Volume
701.7K
Day's Low - High
$54.33 - $55.63
52 Week Low - High
$26.27 - $59.87

Kiniksa Pharmaceuticals International plc Class A Historical Returns

1 Month Return
+ 3.32 %
3 Month Return
+ 20.78 %
1 Year Return
+ 97.31 %
3 Year Return
+ 254.18 %
5 Year Return
+ 266.91 %

Kiniksa Pharmaceuticals International plc Class A Stock Fundamentals & Key Indicators

Check Kiniksa Pharmaceuticals International plc Class A market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.2B

EPS (TTM)

1.2

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

1.46%

PE Ratio (TTM)

59.57

Industry PE ratio

21.553333333333335

PEG Ratio

0

EBITDA

94.9M

Revenue (TTM)

754.0M

Profit Margin

9.69%

Return On Equity TTM

13.74%

Kiniksa Pharmaceuticals International plc Class A Stock Valuation

Track how Kiniksa Pharmaceuticals International plc Class A P/E has moved over time to understand its valuation trends.

Kiniksa Pharmaceuticals International plc Class A in the last 5 years

  • Overview

  • Trends

Lowest (-174.01x)

September 30, 2024

Industry (21.55x)

June 19, 2026

Today (59.57x)

June 19, 2026

Highest (177.55x)

March 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 59.57x

Kiniksa Pharmaceuticals International plc Class A vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kiniksa Pharmaceuticals International plc Class A with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Kiniksa Pharmaceuticals International plc Class A image
Kiniksa Pharmaceuticals International plc Class A
BUY$4.2B266.91%59.579.69%NA
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$22.8B200.63%19.8540.62%NA
Viatris Inc. image
Viatris Inc.
HOLD$18.3B7.78%NA-2.04%2.9899999999999998%
Haleon plc (ADR) image
Haleon plc (ADR)
BUY$39.2BNA17.7415.11%2.12%
ZOETIS INC. image
ZOETIS INC.
BUY$32.4B-57.54%12.6728.04%2.56%
See all

Stock Returns calculator for Kiniksa Pharmaceuticals International plc Class A Stock including INR - Dollar returns

The Kiniksa Pharmaceuticals International plc Class A stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Kiniksa Pharmaceuticals International plc Class A investment value today

Current value as on today

₹2,14,931

Returns

₹1,14,931

(+114.93%)

Returns from Kiniksa Pharmaceuticals International plc Class A Stock

₹97,315 (+97.31%)

Dollar Impact

₹17,617 (+17.62%)

Analyst Recommendation on Kiniksa Pharmaceuticals International plc Class A Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Kiniksa Pharmaceuticals International plc Class A. Average target price of $63.5

Kiniksa Pharmaceuticals International plc Class A Share Price Target

Get share price movements and forecasts by analysts on Kiniksa Pharmaceuticals International plc Class A.

What analysts predicted

13.21%UPSIDE

Target Price

$63.5

Current Price

$55.11

Analyzed by

11 Analysts

Target

$63.50

Kiniksa Pharmaceuticals International plc Class A target price $63.5, a slight upside of 13.21% compared to current price of $55.11. According to 11 analysts rating.

Indian Investors' Interest in Kiniksa Pharmaceuticals International plc Class A Stock

Search interest for Kiniksa Pharmaceuticals International plc Class A Stock has decreased by -75% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-75% versus previous 30 day period

Kiniksa Pharmaceuticals International plc Class A Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
83
79
108
112
122
137
156
180
202
214
Gross Profit
56
48
66
62
56
76
85
97
111
117
Operating Income
0
-16
0
-9
-19
13
20
24
19
29
EBITDA
2
-13
2
-6
-16
15
23
27
23
33
Interest Expense
1
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
2
-14
2
-7
-16
15
22
27
23
32
Income Tax Expense
-22
3
6
5
-8
7
5
8
9
10
Net Income
25
-17
-3
-12
-8
8
17
18
14
22
Net Profit Margin
30.26%
-22.17%
-3.60%
-11.31%
-7.25%
6.20%
11.37%
10.19%
7.02%
10.54%

Kiniksa Pharmaceuticals International plc Class A Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
7
38
220
270
423
677
Gross Profit
0
0
0
-3
-3
29
197
213
362
370
Operating Income
-24
-65
-108
-169
-157
-156
9
-25
-45
77
EBITDA
-23
-65
-107
-167
-154
-154
13
-14
-34
90
Interest Expense
-
-
-
8
3
2
1
-
-
-
Depreciation
-
0
0
2
2
2
2
2
1
1
Income Before Tax
-23
-64
-103
-163
-156
-156
11
-16
-36
88
Income Tax Expense
0
0
0
-2
5
1
-172
-30
7
29
Net Income
-23
-64
-103
-161
-161
-157
183
14
-43
59
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-2094.77%
-409.72%
83.28%
5.21%
-10.21%
8.71%

Kiniksa Pharmaceuticals International plc Class A Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-17
-3
-12
-8
8
17
18
-87
22
Operating Cash Flow
3
5
-2
18
22
28
33
53
50
Investing Cash Flow
25
-46
-6
65
-51
-3
-62
-70
-31
Financing Cash Flow
3
0
6
2
2
10
11
7
6
Change in Cash
33
-41
-1
86
-26
34
-17
-9
24

Kiniksa Pharmaceuticals International plc Class A Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-64
-103
-161
-161
-157
183
14
-43
-43
Operating Cash Flow
-50
-81
-158
-136
-126
5
13
25
25
Investing Cash Flow
0
-239
49
-23
128
-8
-29
37
37
Financing Cash Flow
39
346
84
227
5
2
1
12
12
Change in Cash
-10
26
-25
67
8
0
-14
75
75

Global Institutional Holdings in Kiniksa Pharmaceuticals International plc Class A

Funds
Holdings
Rubric Capital Management LP
4.87%
Cubist Systematic Strategies, LLC
0.89%
Rockefeller Capital Management L.P.
9.35%
Vanguard Group Inc
4.05%
Vanguard Capital Management, LLC
1.73%
See all

Insights on Kiniksa Pharmaceuticals International plc Class A

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, KNSA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, KNSA stock has moved up by 242.9%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 9 quarters, 79.85M → 214.26M (in $), with an average increase of 11.4% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 14.19M → 22.59M (in $), with an average increase of 37.2% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, KNSA has outperformed top 5 stocks with highest market-cap in its industry

About Kiniksa Pharmaceuticals International plc Class A

Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.
OrganisationKiniksa Pharmaceuticals International plc Class A
Headquarters105 Piccadilly, London, United Kingdom, W1J 7NJ
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Sanj K. Patel
E-voting on sharesClick here to vote

Key Management of Kiniksa Pharmaceuticals International plc Class A

Name

Title

Mr. Ross Michael Moat

Executive VP, COO & Principal Operating Officer

Mr. Eben Tessari

Consultant

Ms. Mei Jang

Senior VP & Chief Technical Officer

Ms. Martina Struck Ph.D.

Senior VP & Chief Regulatory Officer

Mr. Sanj K. Patel

CEO & Chairman of the Board

Mr. Mark A. Ragosa C.F.A.

Executive VP & CFO

Dr. John F. Paolini FACC, M.D., Ph.D.

Executive VP & Chief Medical Officer

Mr. Michael R. Megna CPA

Senior VP & Chief Accounting Officer

Mr. Jonathan Kirshenbaum

Investor Relations Officer

Mr. Douglas Barry

Senior VP, Chief Legal Officer & Secretary

FAQs

What is Kiniksa Pharmaceuticals International plc Class A share price today?

Kiniksa Pharmaceuticals International plc Class A share price today is $55.11 as on at the close of the market. Kiniksa Pharmaceuticals International plc Class A share today touched a day high of $55.63 and a low of $54.33.

What is the 52 week high and 52 week low for Kiniksa Pharmaceuticals International plc Class A share?

Kiniksa Pharmaceuticals International plc Class A share touched a 52 week high of $59.87 on and a 52 week low of $26.27 on . Kiniksa Pharmaceuticals International plc Class A stock price today i.e. is closed at $55.11,which is 7.95% down from its 52 week high and 109.78% up from its 52 week low.

What is Kiniksa Pharmaceuticals International plc Class A's market capitalisation today?

Kiniksa Pharmaceuticals International plc Class A market capitalisation is $0.00T as on .

How to invest in Kiniksa Pharmaceuticals International plc Class A Stock (KNSA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kiniksa Pharmaceuticals International plc Class A on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kiniksa Pharmaceuticals International plc Class A Shares that will get you 0.0272 shares as per Kiniksa Pharmaceuticals International plc Class A share price of $55.11 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Kiniksa Pharmaceuticals International plc Class A Stock (KNSA) from India?

Indian investors can start investing in Kiniksa Pharmaceuticals International plc Class A (KNSA) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Kiniksa Pharmaceuticals International plc Class A stock (as per the Rupee-Dollar exchange rate as on ). Based on Kiniksa Pharmaceuticals International plc Class A share’s latest price of $55.11 as on June 19, 2026 at 8:45 am IST, you will get 0.1815 shares of Kiniksa Pharmaceuticals International plc Class A. Learn more about fractional shares .

What are the returns that Kiniksa Pharmaceuticals International plc Class A has given to Indian investors in the last 5 years?

Kiniksa Pharmaceuticals International plc Class A stock has given 266.91% share price returns and 27.5% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?